Rulings
COMPAT: Dismisses ‘defective’ appeal for want of correction despite intimation more than year ago
COMPAT: Dismisses UTV’s impleadment & order rectification application on technical grounds
CCI: Approves Ashok Leyland – Hinduja Foundries merger for revival of latter, absent ‘appreciable adverse effect’ on competition
CCI: Approves Madison’s 2% stake buy in Micromax as no horizontal overlap
CCI: Approves ICU’s acquisition of Pfizer & Hospira Infusions Systems, states no appreciable adverse effect
CCI: approves JV between Allegheny Technologies and General Electric Company
CCI: approves acquisition of Emerson Electric Co. by Nidec Corporation, finds no adverse effect and competitive concern
CCI: Personal money dispute cannot raise any competition concern under Sec 3, dismisses complaint
CCI: Imposes penalties on 3 firms for ‘collusive bidding’ for supply of fans to Indian Railways
CCI: Approves Aspen’s proposition to acquire commercialization rights of Glaxo’s injectable anti-coagulants
Pages
